Clinical Trial Supplies Market Size, Share & Trends Analysis Report By Phase (Phase I, Phase II, Phase III), By Product & Services, By End Use, By Therapeutic Use, By Region, And Segment Forecasts, 2022 - 2030

Table of Contents

Chapter 1. Methodology and Scope
1.1 Market Segmentation & Scope
1.1.1 Phase
1.1.2 Product and Service
1.1.3 End Use
1.1.4 Therapeutic Use
1.1.5 Regional Scope
1.1.6 Estimates and Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 GVR’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details of Primary Research
1.3.5.1 Data for Primary Interviews in North America
1.3.5.2 Data for Primary Interviews in Europe
1.3.5.3 Data for Primary Interviews in APAC
1.3.5.4 Data for Primary Interviews in Latin America
1.3.5.5 Data for Primary Interviews in Middle East & Africa
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.6.1.1 Approach 1: Commodity Flow Approach
1.6.2 Volume Price Analysis (Model 2)
1.6.2.1 Approach 2: Volume Price Analysis
1.7 List of Secondary Sources
1.8 Objectives
1.8.1 Objective 1
1.8.2 Objective 2
Chapter 2. Executive Summary
2.1 Market Outlook
Chapter 3. Clinical Trial Supplies Market Variables, Trends, & Scope
3.1 Market Dynamics
3.1.1 Market Driver Analysis
3.1.1.1 Expansion of Clinical Trial Sites
3.1.1.2 Growing R&D in Biologics and Biosimilars
3.1.1.3 Advancements in Supply Chain Technology
3.1.1.4 Increase in Comparator Sourcing
3.1.2 Market Restraint Analysis
3.1.2.1 Presence of Stringent Regulatory Policies
3.1.2.2 High Possibility of Counterfeiting Drugs
3.1.3 Penetration & Growth Prospect Mapping
3.1.4 SWOT Analysis by PESTEL
3.1.5 Industry Analysis-Porter’s
3.1.6 Clinical Trial Supplies Market: Impact of COVID-19
3.1.6.1 Supply Chain
3.1.6.2 Changing Market Trends
Chapter 4. Clinical Trial Supplies Market: Segment Analysis, By Phase, 2017 - 2030 (USD Million)
4.1 Definitions and Scope
4.2 Phase Market Share Analysis
4.3 Segment Dashboard
4.4 Clinical trial supplies Market By Phase
4.4.1 Phase I
4.4.1.1 Phase I Market Estimates and Forecast, 2017 - 2030 (In Million)
4.4.2 Phase II
4.4.2.1 Phase II Market Estimates and Forecast, 2017 - 2030 (In Million)
4.4.3 Phase III
4.4.3.1 Phase III Market Estimates and Forecast, 2017 - 2030 (In Million)
4.4.4 Others
4.4.4.1 Others Market Estimates and Forecast, 2017 - 2030 (In Million)
Chapter 5. Clinical Trial Supplies Market: Segment Analysis, By Services, 2017 - 2030 (USD Million)
5.1 Definitions and Scope
5.2 Product and Service Market Share Analysis
5.3 Segment Dashboard
5.4 Clinical Trial Supplies Market by Services
5.4.1 Manufacturing
5.4.1.1 Manufacturing Market Estimates and Forecast, 2017 - 2030 (In Million)
5.4.2 Storage & Distribution
5.4.2.1 Storage & Distribution Market Estimates and Forecast, 2017 - 2030 (In Million)
5.4.2.2 Cold Chain Distribution
5.4.2.3 Non-Cold Chain Distribution
5.4.3 Supply Chain Management
5.4.3.1 Supply Chain Management Market Estimates and Forecast, 2017 - 2030 (In Million)
5.4.4 Comparator Sourcing
5.4.4.1 Comparator Sourcing Market Estimates and Forecast, 2017 - 2030 (In Million)
Chapter 6. Clinical Trial Supplies Market: Segment Analysis, By End Use, 2017 - 2030 (USD Million)
6.1 Definitions and Scope
6.2 End-Use Market Share Analysis
6.3 Segment Dashboard
6.4 Clinical Trial Supplies Market by End Use
6.4.1 Pharmaceutical
6.4.1.1 Pharmaceutical Market Estimates and Forecast, 2017 - 2030 (In Million)
6.4.2 Biologics
6.4.2.1 Biologics Market Estimates and Forecast, 2017 - 2030 (In Million)
6.4.3 Medical Devices
6.4.3.1 Medical Device Market Estimates and Forecast, 2017 - 2030 (In Million)
6.4.4 Others
6.4.4.1 Others Market Estimates and Forecast, 2017 - 2030 (In Million)
Chapter 7. Clinical Trial Supplies Market: Segment Analysis, By Therapeutic Use, 2017 - 2030 (USD Million)
7.1 Definitions and Scope
7.2 Therapeutic Use Market Share Analysis
7.3 Segment Dashboard
7.4 Clinical Trial Supplies Market by Therapeutic Use
7.4.1 Oncology
7.4.1.1 Oncology Market Estimates and Forecast, 2017 - 2030 (In Million)
7.4.2 Central Nervous System (CNS) Disorders
7.4.2.1 CNS Market Estimates and Forecast, 2017 - 2030 (In Million)
7.4.3 Cardiovascular
7.4.3.1 Cardiovascular Market Estimates and Forecast, 2017 - 2030 (In Million)
7.4.4 Infectious diseases
7.4.4.1 Infectious Diseases Market Estimates and Forecast, 2017 - 2030 (In Million)
7.4.5 Metabolic disorders
7.4.5.1 Metabolic Disorders Market Estimates and Forecast, 2017 - 2030 (In Million)
7.4.6 Dermatology
7.4.6.1 Dermatology Market Estimates and Forecast, 2017 - 2030 (In Million)
7.4.7 Ophthalmology
7.4.7.1 Ophthalmology Market Estimates and Forecast, 2017 - 2030 (In Million)
7.4.8 Respiratory Diseases
7.4.8.1 Respiratory Diseases Market Estimates and Forecast, 2017 - 2030 (In Million)
7.4.9 Others
7.4.9.1 Others Market Estimates and Forecast, 2017 - 2030 (In Million)
Chapter 8. Clinical Trial Supplies Market: Regional Market Analysis, 2017 - 2030 (USD Million)
8.1 Regional Market Dashboard
8.2 Definitions and Scope
8.3 Regional Market Share Analysis
8.4 North America
8.4.1 North America Market Estimates and Forecast, 2017 - 2030
8.4.2 U.S.
8.4.2.1 U.S. Market Estimates and Forecast, 2017 - 2030
8.4.3 Canada
8.4.3.1 Canada Market Estimates and Forecast, 2017 - 2030
8.5 Europe
8.5.1 Europe Market Estimates and Forecast, 2017 - 2030
8.5.2 Germany
8.5.2.1 Germany Market Estimates and Forecast, 2017 - 2030
8.5.3 U.K.
8.5.3.1 U.K. Market Estimates and Forecast, 2017 - 2030
8.5.4 France
8.5.4.1 France Market Estimates and Forecast, 2017 - 2030
8.5.5 Italy
8.5.5.1 Italy Market Estimates and Forecast, 2017 - 2030
8.5.6 Spain
8.5.6.1 Spain Market Estimates and Forecast, 2017 - 2030
8.5.7 Netherlands
8.5.7.1 Netherlands Market Estimates and Forecast, 2017 - 2030
8.5.8 Belgium
8.5.8.1 Belgium Market Estimates and Forecast, 2017 - 2030
8.5.9 Switzerland
8.5.9.1 Switzerland Market Estimates and Forecast, 2017 - 2030
8.5.10 Russia
8.5.10.1 Russia Market Estimates and Forecast, 2017 - 2030
8.6 Asia Pacific
8.6.1 Asia Pacific Market Estimates and Forecast, 2017 - 2030
8.6.2 China
8.6.2.1 China Market Estimates and Forecast, 2017 - 2030
8.6.3 Japan
估计和预测,2017年8.6.3.1日本市场- 2030
8.6.4 India
8.6.4.1 India Market Estimates and Forecast, 2017 - 2030
8.6.5 Australia
8.6.5.1 Australia Market Estimates and Forecast, 2017 - 2030
8.6.6 South Korea
8.6.6.1 South Korea Market Estimates and Forecast, 2017 - 2030
8.6.7 Malaysia
8.6.7.1 Malaysia Market Estimates and Forecast, 2017 - 2030
8.6.8 Indonesia
8.6.8.1 Indonesia Market Estimates and Forecast, 2017 - 2030
8.6.9 Singapore
8.6.9.1 Singapore Market Estimates and Forecast, 2017 - 2030
8.6.10 Philippines
8.6.10.1 Philippines Market Estimates and Forecast, 2017 - 2030
8.7 Latin America
8.7.1 Latin America Market Estimates and Forecast, 2017 - 2030
8.7.2 Brazil
8.7.2.1 Brazil Market Estimates and Forecast, 2017 - 2030
8.7.3 Mexico
8.7.3.1 Mexico Market Estimates and Forecast, 2017 - 2030
8.7.4 Argentina
8.7.4.1 Argentina Market Estimates and Forecast, 2017 - 2030
8.7.5 Colombia
8.7.5.1 Colombia Market Estimates and Forecast, 2017 - 2030
8.8 Middle East and Africa
8.8.1 Middle East & Africa Market Estimates and Forecast, 2017 - 2030
8.8.2 South Africa
8.8.2.1 South Africa Market Estimates and Forecast, 2017 - 2030
8.8.3 Saudi Arabia
8.8.3.1 Saudi Arabia Market Estimates and Forecast, 2017 - 2030
8.8.4 UAE
8.8.4.1 UAE Market Estimates and Forecast, 2017 - 2030
Chapter 9. Clinical Trial Supplies Market - Competitive Analysis
9.1 Company Profiles
9.1.1 Almac Group
9.1.1.1 Company Overview
9.1.1.2 Service Benchmarking
9.1.1.3 Strategic Initiatives
9.1.2 Biocair
9.1.2.1 Company Overview
9.1.2.2 Service Benchmarking
9.1.2.3 Strategic Initiatives
9.1.3 Catalent, Inc.
9.1.3.1 Company Overview
9.1.3.2 Financial Performance
9.1.3.3 Service Benchmarking
9.1.3.4 Strategic Initiatives
9.1.4 KLIFO
9.1.4.1 Company Overview
9.1.4.2 Service Benchmarking
9.1.4.3 Strategic Initiatives
9.1.5 Movianto (Walden Group)
9.1.5.1 Company Overview
9.1.5.2 Service Benchmarking
9.1.5.3 Strategic Initiatives
9.1.6 PCI Pharma Services
9.1.6.1 Company Overview
9.1.6.2 Service Benchmarking
9.1.6.3 Strategic Initiatives
9.1.7 Sharp
9.1.7.1 Company Overview
9.1.7.2 Service Benchmarking
9.1.7.3 Strategic Initiatives
9.1.8 Thermo Fischer Scientific, Inc.
9.1.8.1 Company Overview
9.1.8.2 Financial Performance
9.1.8.3 Service Benchmarking
9.1.8.4 Strategic Initiatives
9.1.9 Marken
9.1.9.1 Company Overview
9.1.9.2 Service Benchmarking
9.1.9.3 Strategic Initiatives
9.1.10 Parexel International Corporation
9.1.10.1 Company Overview
9.1.10.2 Financial Performance
9.1.10.3 Service Benchmarking
9.1.10.4 Strategic Initiatives
9.1.11 Piramal Pharma Solutions
9.1.11.1公司view
9.1.11.2 Financial Performance
9.1.11.3 Service Benchmarking
9.1.11.4 Strategic Initiatives
9.1.12 UDG Healthcare
9.1.12.1 Company Overview
9.1.12.2 Financial Performance
9.1.12.3 Service Benchmarking
9.1.12.4 Strategic Initiatives
9.1.13 EUROFINS
9.1.13.1 Company Overview
9.1.13.2 Financial Performance
9.1.13.3 Service Benchmarking
9.1.13.4 Strategic Initiatives
9.1.14 PRA Health Sciences
9.1.14.1 Company Overview
9.1.14.2 Financial Performance
9.1.14.3 Service Benchmarking
9.1.14.4 Strategic Initiatives
9.1.15 Liveo Research
9.1.15.1 Company Overview
9.1.15.2 Financial Performance
9.1.15.3 Service Benchmarking
9.1.15.4 Strategic Initiatives

List of Tables

Table 1 List of secondary sources
Table 2 List of Abbreviation

List of Figures

Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market summary (USD Million, 2016)
Fig. 8 Market trends & outlook
Fig. 9 Clinical trial supplies market: Market segmentation
Fig. 10 Clinical trial supplies market revenue (USD Million), 2017 - 2030
Fig. 11 Key Opportunities Prioritized
Fig. 12 Clinical trial supplies: Porter’s analysis
Fig. 13 Clinical trial supplies: PESTEL analysis
Fig. 14 Clinical trial supplies market phase outlook key takeaways
Fig. 15 Clinical trial supplies market: Phase movement analysis
Fig. 16 Phase I market, 2017 - 2030 (USD Million)
Fig. 17 Phase II market, 2017 - 2030 (USD Million)
Fig. 18 Phase III market, 2017 - 2030 (USD Million)
Fig. 19 Others market, 2017 - 2030 (USD Million)
Fig. 20 Clinical trial supplies market Services outlook key takeaways
Fig. 21 Clinical trial supplies market: Services movement analysis
Fig. 22 Manufacturing market, 2017 - 2030 (USD Million)
Fig. 23 Storage & distribution market, 2017 - 2030 (USD Million)
Fig. 24 Cold chain-based storage & distribution market, 2017 - 2030 (USD Million)
Fig. 25 Non-cold chain-based storage & distribution market, 2017 - 2030 (USD Million)
Fig. 26 Supply chain management market, 2017 - 2030 (USD Million)
Fig. 27 Comparator Sourcing market, 2017 - 2030 (USD Million)
Fig. 28 Clinical trial supplies market end-use outlook key takeaways
Fig. 29 Clinical trial supplies market: End-use movement analysis
Fig. 30 Pharmaceuticals market, 2017 - 2030 (USD Million)
Fig. 31 Biologics market, 2017 - 2030 (USD Million)
Fig. 32 Medical device market, 2017 - 2030 (USD Million)
Fig. 33 Other end use market, 2017 - 2030 (USD Million)
Fig. 34 Clinical trial supplies market therapeutic use outlook key takeaways
Fig. 35 Clinical trial supplies market: Therapeutic use movement analysis
Fig. 36 Oncology market, 2017 - 2030 (USD Million)
Fig. 37 CNS market, 2017 - 2030 (USD Million)
Fig. 38 Cardiovascular market, 2017 - 2030 (USD Million)
Fig. 39 Infectious disease market, 2017 - 2030 (USD Million)
Fig. 40 Metabolic disorders market, 2017 - 2030 (USD Million)
Fig. 41 Dermatology market, 2017 - 2030 (USD Million)
Fig. 42 Ophthalmology market, 2017 - 2030 (USD Million)
Fig. 43 Rare Diseases market, 2017 - 2030 (USD Million)
Fig. 44 Others therapeutic use market, 2017 - 2030 (USD Million)
Fig. 45 Regional marketplace: Key takeaways
Fig. 46 North America clinical trial supplies market, 2013 - 2024 (USD Million)
Fig. 47 U.S. clinical trial supplies market, 2017 - 2030 (USD Million)
Fig. 48 Canada clinical trial supplies market, 2017 - 2030 (USD Million)
Fig. 49 Europe clinical trial supplies market, 2017 - 2030 (USD Million)
Fig. 50 U.K. clinical trial supplies market, 2017 - 2030 (USD Million)
Fig. 51 Germany clinical trial supplies market, 2017 - 2030 (USD Million)
Fig. 52 France clinical trial supplies market, 2017 - 2030 (USD Million)
Fig. 53 Italy clinical trial supplies market, 2017 - 2030 (USD Million)
Fig. 54 Spain clinical trial supplies market, 2017 - 2030 (USD Million)
Fig. 55 Netherlands clinical trial supplies market, 2017 - 2030 (USD Million)
Fig. 56 Belgium clinical trial supplies market, 2017 - 2030 (USD Million)
Fig. 57 Switzerland clinical trial supplies market, 2017 - 2030 (USD Million)
Fig. 58 Russia clinical trial supplies market, 2017 - 2030 (USD Million)
Fig. 59 Asia Pacific clinical trial supplies market, 2017 - 2030 (USD Million)
Fig. 60 Japan clinical trial supplies market, 2017 - 2030 (USD Million)
Fig. 61 China clinical trial supplies market, 2017 - 2030 (USD Million)
Fig. 62 India clinical trial supplies market, 2017 - 2030 (USD Million)
Fig. 63 Australia clinical trial supplies market, 2017 - 2030 (USD Million)
Fig. 64 South Korea clinical trial supplies market, 2017 - 2030 (USD Million)
Fig. 65 Malaysia clinical trial supplies market, 2017 - 2030 (USD Million)
Fig. 66 Indonesia clinical trial supplies market, 2017 - 2030 (USD Million)
Fig. 67 Singapore clinical trial supplies market, 2017 - 2030 (USD Million)
Fig. 68 Philippines clinical trial supplies market, 2017 - 2030 (USD Million)
Fig. 69 Latin America clinical trial supplies market, 2017 - 2030 (USD Million)
Fig. 70 Brazil clinical trial supplies market, 2017 - 2030 (USD Million)
Fig. 71 Mexico clinical trial supplies market, 2017 - 2030 (USD Million)
Fig. 72 Argentina clinical trial supplies market, 2017 - 2030 (USD Million)
Fig. 73 Colombia clinical trial supplies market, 2017 - 2030 (USD Million)
Fig. 74 MEA clinical trial supplies market, 2017 - 2030 (USD Million)
Fig. 75 South Africa clinical trial supplies market, 2017 - 2030 (USD Million)
图76沙特阿拉伯临床试验物资市场t, 2017 - 2030 (USD Million)
Fig. 77 UAE clinical trial supplies market, 2017 - 2030 (USD Million)